Published in Cardiovascular Week, January 17th, 2005
According to research published in the Journal of Cardiovascular Pharmacology, "Labedipinedilol-A is a novel 1, 4-dihydropyridine-type calcium antagonist with alpha-receptor blocking activity. [Our] study investigates the effects of labedipinedilol-A on mitogen-induced proliferation of rat vascular smooth muscle cells (VSMCs)."
S.F. Liou and colleagues of Kaohsiung Medical University in Taiwan explained, "Labedipinedilol-A's inhibition on cell proliferation was measured by the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.